Recruitment completed for RAINBOWFISH clinical trial of risdiplam

Following our request to receive important and timely updates on their SMA clinical programme, Roche has informed us that worldwide recruitment has completed for the RAINBOWFISH clinical trial, which investigates the efficacy and safety of risdiplam in infants with pre-symptomatic SMA Type 1. This milestone marks the enrolment of 26 participants from across the globe.